The Unexpected Risks of COVID-19 on Asthma Control in Children

J Allergy Clin Immunol Pract. 2020 Sep;8(8):2489-2491. doi: 10.1016/j.jaip.2020.05.027. Epub 2020 Jun 1.

Abstract

Much is being learned about clinical outcomes for adult COVID-19 patients with underlying chronic conditions; however, there is less coverage on how the COVID-19 pandemic impacts the management of chronic medical conditions, such as asthma, in children and youth. Asthma is a common chronic medical condition in children that is uniquely susceptible to changes brought on by COVID-19. Sudden dramatic changes in the environment, medical practice, and medication use have altered the asthma management landscape with potential impacts on asthma outcomes. In this paper, we review how changes in transportation and travel patterns, school attendance, physical activity, and time spent indoors, along with changes in health care delivery since the start of the pandemic, all play a contributing role in asthma control in children. We review potentially important influences of asthma control in children during the COVID-19 pandemic worthy of further study.

Keywords: Asthma; COVID-19; Coronavirus; Pediatrics.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Asthma / epidemiology*
  • Asthma / therapy*
  • Betacoronavirus
  • COVID-19
  • Child
  • Child, Preschool
  • Chronic Disease
  • Coronavirus Infections / epidemiology*
  • Delivery of Health Care / organization & administration
  • Emergency Service, Hospital / statistics & numerical data
  • Environment
  • Exercise
  • Humans
  • Medication Adherence
  • Pandemics
  • Pneumonia, Viral / epidemiology*
  • Risk Factors
  • SARS-CoV-2
  • Schools
  • Socioeconomic Factors
  • Telemedicine / organization & administration
  • Travel